A randomized phase II study of nivolumab plus ipilimumab versus standard of care in previously untreated and advanced non-clear cell renal cell carcinoma (Suniforecast)
Ahrens, M Escudier, B Boleti, E Grimm, MO Goupir, MG Barthelemy, P Gravis, G Bedekes, J Ivanyi, P Panic, A
Ahrens, M
Escudier, B
Boleti, E
Grimm, MO
Goupir, MG
Barthelemy, P
Gravis, G
Bedekes, J
Ivanyi, P
Panic, A
Citations
Altmetric:
Abstract
Affiliation
Description
Date
2020
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Ahrens M, Escudier B, Boleti E, Grimm MO, Goupir MG, Barthelemy P, et al. A Randomized Phase II Study of Nivolumab Plus Ipilimumab Versus Standard of Care in Previously Untreated and Advanced Non-Clear Cell Renal Cell Carcinoma (Suniforecast). Oncology Research and Treatment. 2020;43:226-